Diabetes Mellitus, Type 2: Clinical Trials

10,086 trials for Diabetes Mellitus, Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6738 completed, 1189 unknown, 728 recruiting, 485 terminated. 3746 Not applicable, 1437 Phase 3, 1186 Phase 4, 1096 Phase 1, 1025 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3746Completed 2263, Unknown 551, Recruiting 355, Not yet recruiting 186, Active not recruiting 157, Terminated 112, Withdrawn 72, Enrolling by invitation 39, Suspended 11
Phase 31437Completed 1096, Terminated 111, Unknown 86, Recruiting 59, Withdrawn 30, Not yet recruiting 26, Active not recruiting 24, Suspended 4, Enrolling by invitation 1
Phase 41186Completed 803, Unknown 167, Terminated 84, Recruiting 56, Withdrawn 30, Not yet recruiting 24, Active not recruiting 15, Enrolling by invitation 4, Suspended 3
Phase 11096Completed 892, Unknown 67, Terminated 53, Recruiting 40, Active not recruiting 16, Not yet recruiting 16, Withdrawn 11, Suspended 1
Phase 21025Completed 720, Unknown 90, Terminated 84, Recruiting 45, Active not recruiting 31, Withdrawn 28, Not yet recruiting 25, Enrolling by invitation 2
Early Phase 167Completed 41, Unknown 10, Recruiting 7, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 2, Terminated 2, Withdrawn 1

Follow Diabetes Mellitus, Type 2: new trials by email Literature Review of Diabetes Mellitus, Type 2 trials Research Report on Diabetes Mellitus, Type 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance
Phase 2WithdrawnUniversity of Arizona2030-04-152025-07-30
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention - Type 2 Diabetes, Medication Adherence
Not applicableNot yet recruitingUniversity of Alabama at Birmingham452029-05-012026-05-20
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Tirzepatide + Standard Therapy (Intervention Group), Standard Oral Antidiabetic Drugs (OADs) - Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Not applicableNot yet recruitingAkhtar Saeed Medical and Dental College522027-12-122026-10-29
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
MitoQ (mitoquinol mesylate), Placebo - Type 2 Diabetes (T2DM), Endothelial Dysfunction
Not applicableNot yet recruitingMedical College of Wisconsin402027-10-012026-10-30
Implementation Support for HEARTS-Based Hypertension and Diabetes Care in Guatemala
HEARTS implementation support, Routine HEARTS implementation - Hypertension (HTN), Type 2 Diabetes
Not applicableNot yet recruitingUniversity of Michigan14402027-10-012026-11-12
South Asians With Type 2 Diabetes at Risk for Depression
CHW-led T2D Intervention - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1002027-08-012026-05-19
Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
INTEGRATE-CHW, Usual Care - Hypertension (HTN), CKD - Chronic Kidney Disease
Not applicableNot yet recruitingFlorida International University2002027-07-152026-11-05
cfMSC Therapy for Diabetes
cfMSC therapy for diabetes - Type II Diabetes Mellitus
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-11-02
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-11-06
Tracking Income Dynamics and Everyday Health Study
Preventative health review invitation early in SNAP cycle, Financial counseling invitation early in the SNAP cycle, Aim 3 follow-up call early in the SNAP period - HIV, Hypertension
Not applicableNot yet recruitingUniversity of Pennsylvania4002027-03-012026-10-19
Mindful Eating and Mindful Movement for Persons With Type 2 Diabetes Mellitus
Standard of Care Diet and Exercise Group, Mindful Eating and Mindful Movement (MEMO) Group - Type 2 Diabetes
Not applicableNot yet recruitingNortheastern University602027-03-012026-09-18
Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Integrated Digital Health (IDH) platform, Provider engagement - Diabetes, Diabetes Type 2
Not applicableNot yet recruitingYale University3002027-03-012026-09-29
Testing a Diabetes Care Program in Rural and Low-Income Clinics
Community Health Worker-led diabetes program - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingThe University of Texas Medical Branch, Galveston2002027-03-012026-08-14
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
Continuous Glucose Monitoring (CGM), Adaptive dietary intervention (GEM) - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1202027-02-012026-08-13
Clinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp Technology
Obesity Type 2 Diabetes Mellitus, Obese Adults
Not yet recruitingProfil Institut für Stoffwechselforschung GmbH502027-02-012026-11-03
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
Supervised exercise training, protein supplement, Standardized lifestyle counseling - Type 2 Diabetes (T2DM), Obesity & Overweight
Not applicableNot yet recruitingGerman Diabetes Center942027-02-012026-11-09
The PRECISE-DIET Trial
Personalised dietary intervention, Standard dietary counselling - Type 2 Diabetes, Nutrition
Not applicableNot yet recruitingSteno Diabetes Center Copenhagen1302027-02-012026-11-16
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Semaglutide - Diabetes Mellitus, Type 2
Not yet recruitingNovo Nordisk A/S6002027-01-312026-09-18
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
AZD6234, Placebo - Obesity, Overweight
Phase 3Not yet recruitingAstraZeneca3302027-01-042026-11-06
Nutrition Intervention Optimization to Better Utilize Resources and Support Health
Meal kits, No-prep meals, Culinary nutrition classes - Diabete Type 2, Obesity & Overweight
Not applicableNot yet recruitingTufts University4002027-01-012026-10-19

Showing 20 of 10086. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus (1991)  ·  Obesity (1032)  ·  Insulin Resistance (592)  ·  Diabetes Mellitus, Type 1 (444)  ·  Hypertension (366)  ·  Cardiovascular Diseases (316)  ·  Overweight (293)  ·  Motor Activity (277)  ·  Prediabetic State (211)  ·  Renal Insufficiency, Chronic (189)  ·  Metabolic Syndrome (175)  ·  Dyslipidemias (167)  ·  Glucose Intolerance (161)  ·  Hyperglycemia (152)

Broader conditions

Nutritional and Metabolic Diseases (10072)  ·  Endocrine System Diseases (10019)  ·  Metabolic Diseases (9968)  ·  Glucose Metabolism Disorders (9951)  ·  Diabetes Mellitus (8095)  ·  Pathological Conditions, Signs and Symptoms (1824)  ·  Signs and Symptoms (1363)  ·  Nutrition Disorders (1147)  ·  Body Weight (1134)  ·  Overnutrition (1120)  ·  Overweight (835)  ·  Cardiovascular Diseases (774)  ·  Vascular Diseases (754)  ·  Hyperinsulinism (718)  ·  Behavior (580)

Interventions

Metformin (709)  ·  Insulin Glargine (355)  ·  Sitagliptin Phosphate (334)  ·  semaglutide (247)  ·  dapagliflozin (226)  ·  Pioglitazone (208)  ·  Liraglutide (199)  ·  empagliflozin (195)  ·  glimepiride (178)  ·  Exercise (166)  ·  Insulin (155)  ·  Exenatide (148)  ·  Vildagliptin (137)  ·  Insulin Aspart (117)  ·  Insulin Detemir (117)

Sponsors

Novo Nordisk A/S (638)  ·  AstraZeneca (330)  ·  Eli Lilly and Company (236)  ·  Sanofi (184)  ·  Merck Sharp & Dohme LLC (181)  ·  Boehringer Ingelheim (130)  ·  GlaxoSmithKline (129)  ·  Takeda (101)  ·  Pfizer (76)  ·  Novartis Pharmaceuticals (69)  ·  Hoffmann-La Roche (68)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (57)  ·  University of Aarhus (57)  ·  Chong Kun Dang Pharmaceutical (52)  ·  Jiangsu HengRui Medicine Co., Ltd. (47)

Countries

United States (3249)  ·  China (871)  ·  Germany (750)  ·  Canada (749)  ·  United Kingdom (562)  ·  South Korea (540)  ·  Denmark (466)  ·  Mexico (450)  ·  Spain (425)  ·  Italy (415)  ·  France (405)  ·  India (390)  ·  Japan (389)  ·  Poland (350)  ·  Turkey (Türkiye) (339)

Results publications

PMID 38770818, PMID 39963952, PMID 22236356, PMID 25387217, PMID 33166419, PMID 25504028, PMID 35472672, PMID 31903692, PMID 32998732, PMID 32501595, PMID 35044568, PMID 38682786, PMID 22913891, PMID 31606880, PMID 34213819, PMID 23010561, PMID 26894924, PMID 32267058, PMID 39171639, PMID 26580237, PMID 37435938, PMID 24517339, PMID 21450987, PMID 21883806, PMID 22193143, PMID 22234149, PMID 22862847, PMID 23186975, PMID 24786834, PMID 27402391, PMID 27977934, PMID 30615985, PMID 31769496, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382, PMID 32648108, PMID 35210595, PMID 39535683, PMID 17878242, PMID 18093207, PMID 19245711, PMID 19491536, PMID 19793357, PMID 21209033, PMID 22055210, PMID 23748506, PMID 24561125, PMID 26691396

NIH funding

2009 (55), 2015 (45), 2008 (41), 2016 (37), 2017 (36), 2019 (35), 2018 (33), 2014 (31), 2023 (29), 2025 (27), 2005 (21), 2004 (5), P30DK111024 (5), R01DK024092 (5), UL1RR024150 (5)